Table 2 Cancer-related characteristics of the participants and associations of CAM use
Total | Women | Men | CAM level 21 | CAM level 3 2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | n = 468 | % | n = 315 | % | n = 153 | % | n = 143 | p-value | % | n = 346 | p-value | ||
Cancer site** | |||||||||||||
Breast | 39.1 | 183 | 57.8 | 172 | 0.7 | 1 | < 0.001* | 42.0 | 71 | 0.001* | 80.7 | 138 | 0.474* |
Gastrointestinal | 13.7 | 64 | 10.5 | 33 | 20.3 | 31 | 0.004* | 22.6 | 14 | 0.064* | 79.0 | 49 | 0.964* |
Male genitalia | 11.1 | 52 | 0.0 | 0 | 34.0 | 52 | < 0.001* | 18.2 | 9 | 0.028* | 62.5 | 30 | 0.003* |
Lymphoma | 8.8 | 41 | 6.3 | 20 | 13.7 | 21 | 0.008* | 25.6 | 10 | 0.318* | 74.4 | 29 | 0.537* |
Female genitalia | 8.1 | 38 | 12.1 | 38 | 0.0 | 0 | < 0.001* | 41.7 | 15 | 0.237* | 91.7 | 33 | 0.049* |
Malignant melanoma | 4.7 | 22 | 4.4 | 14 | 5.2 | 8 | 0.707* | 27.3 | 6 | 0.571* | 72.7 | 16 | 0.433^ |
Head and neck | 3.8 | 18 | 1.6 | 5 | 8.5 | 16 | < 0.001* | 23.5 | 4 | 0.448* | 82.4 | 14 | 1.000^ |
Lung | 3.2 | 15 | 2.5 | 8 | 4.7 | 7 | 0.268^ | 26.7 | 4 | 1.000^ | 78.6 | 11 | 1.000^ |
Sarcoma | 3.0 | 14 | 3.8 | 12 | 1.3 | 2 | 0.160^ | 35.7 | 5 | 0.779^ | 85.7 | 12 | 0.744^ |
Skin | 2.4 | 11 | 2.5 | 8 | 2.0 | 3 | 1.000^ | 20.0 | 2 | 0.509* | 50.0 | 5 | 0.039^ |
Leukemia | 2.4 | 11 | 2.2 | 7 | 2.6 | 4 | 0.755^ | 27.3 | 3 | 1.000^ | 72.7 | 8 | 0.707^ |
Bone marrow | 2.1 | 10 | 1.9 | 6 | 2.6 | 4 | 0.735^ | 50.0 | 5 | 0.308^ | 100 | 10 | 0.129^ |
Brain tumor | 1.9 | 9 | 0.6 | 2 | 4.6 | 7 | 0.007^ | 33.3 | 2 | 1.000^ | 100 | 6 | 0.350^ |
Thyroid gland | 1.9 | 9 | 2.5 | 8 | 0.7 | 1 | 0.163* | 50.0 | 4 | 0.448^ | 87.5 | 7 | 1.000^ |
Bladder | 1.7 | 8 | 0.3 | 1 | 4.6 | 7 | 0.002^ | 0.0 | 0 | 0.057^ | 75.0 | 6 | 0.679^ |
Kidney | 1.3 | 6 | 0.3 | 1 | 3.3 | 5 | 0.016^ | 40.0 | 2 | 0.665^ | 100 | 5 | 0.589^ |
Liver | 1.1 | 5 | 0.6 | 2 | 2.0 | 3 | 0.336^ | 50.0 | 2 | 0.600^ | 100 | 5 | 0.589^ |
Esophagus | 1.1 | 5 | 0.3 | 1 | 2.6 | 4 | 0.041^ | 0.0 | 0 | 0.177^ | 60.0 | 3 | 0.287* |
Pancreas | 0.6 | 3 | 0.3 | 1 | 1.3 | 2 | 0.250^ | 0.0 | 0 | 0.554^ | 66.7 | 2 | 0.511^ |
Gallbladder | 0.6 | 3 | 0.6 | 2 | 0.7 | 1 | 1.000^ | 0.0 | 0 | 1.000^ | 66.7 | 2 | 0.511* |
Neuroendocrine | 0.4 | 2 | 0.6 | 2 | 0.0 | 0 | 1.000^ | 50.0 | 1 | 0.549^ | 100 | 2 | 1.000^ |
Other cancer sites | 2.1 | 10 | 2.9 | 9 | 0.7 | 1 | 0.177^ | 30.0 | 3 | 1.000^ | 90.0 | 9 | 0.696* |
In active cancer treatment | 0.332* | 0.302* | 0.055* | ||||||||||
Yes | 33.8 | 158 | 35.2 | 111 | 30.7 | 47 | 36.0 | 54 | 84.0 | 126 | |||
No | 66.2 | 310 | 64.8 | 204 | 69.3 | 106 | 31.1 | 89 | 76.1 | 220 | |||